Cargando…

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma

Metabolic rearrangement is a marker of cancer that has been widely studied in recent years. One of the major metabolic characteristics of tumor cells is the high levels of glycolysis, even under aerobic conditions, a phenomenon that is called the “Warburg effect.” We investigated the expression and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Chen, Mingying, Liu, Meihong, Xu, Yingkun, Wu, Guangzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850857/ https://www.ncbi.nlm.nih.gov/pubmed/33564363 http://dx.doi.org/10.1155/2021/6699808

Ejemplares similares

Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N(6)-Methyladenosine RNA Methylation Regulators
por: Zhang, Yan, et al.
Publicado: (2021)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Qi, Xiaochen, et al.
Publicado: (2021)

A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
por: He, Liping, et al.
Publicado: (2023)

Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target
por: Wu, Guangzhen, et al.
Publicado: (2021)

A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
por: Xu, Yingkun, et al.
Publicado: (2020)

Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
por: Xu, Yingkun, et al.
Publicado: (2020)

Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Yonghao, et al.
Publicado: (2022)

Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma
por: Li, Cheng Shan, et al.
Publicado: (2021)

The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients
por: Wang, Zicheng, et al.
Publicado: (2022)

Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration
por: Wu, Guangzhen, et al.
Publicado: (2020)

Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis
por: Zhang, Peizhi, et al.
Publicado: (2023)

Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021)

Analysis of genomes and transcriptomes of clear cell renal cell carcinomas identifies mutations and gene expression changes in the TGF-beta pathway
por: Che, Xiangyu, et al.
Publicado: (2022)

HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth
por: Mao, Huajie, et al.
Publicado: (2023)

Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
por: Wu, Guangzhen, et al.
Publicado: (2019)

A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma
por: Huang, Shuo, et al.
Publicado: (2022)

Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Guo, Tuanjie, et al.
Publicado: (2022)

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
por: Xu, Guang-hua, et al.
Publicado: (2018)

TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma
por: Li, Jianyi, et al.
Publicado: (2020)

GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
por: Yao, Lei, et al.
Publicado: (2022)

TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro
por: Xu, Yingkun, et al.
Publicado: (2020)

Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
por: Huang, Shuaishuai, et al.
Publicado: (2023)

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma
por: Meng, Quan, et al.
Publicado: (2021)

The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinoma
por: Wang, Qifei, et al.
Publicado: (2023)

Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma
por: Wang, Gang, et al.
Publicado: (2021)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy
por: Xiang, Zhenfei, et al.
Publicado: (2021)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma
por: Li, Xiunan, et al.
Publicado: (2022)

Differentially expressed autophagy-related genes are potential prognostic and diagnostic biomarkers in clear-cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ottm9rilpeatf3rshlkf0vrf4n